A vaccine directed against tumor blood vessels suppress tumor growth and metastasis
2014-11-07
(Press-News.org) In a new study published in the scientific journal Oncotarget researchers from Uppsala University show that a therapeutic vaccine directed against tumor vessels can reduce tumor burden and suppress formation of spontaneous lung metastases in a mouse model for metastatic breast cancer.
The target molecule of the immunization strategy is the extra domain-A (ED-A) of fibronectin, a protein domain which is highly selective for the tumor vasculature in the adult.
"The vaccination approach we have employed is not prophylactic but therapeutic, meaning that immunity was induced after the onset of tumorigenesis - a scenario that resembles the clinical conditions much more closely than prophylactic immunization studies, says Anna-Karin Olsson, researcher at the Department of Medical Biochemistry and Microbiology at Uppsala University", who has led the study.
The therapeutic effect was significant, despite the aggressive nature of the tumor model. Moreover, the vaccine induced an 80 percent reduction metastasis, which is an important finding considering that a majority of all deaths by cancer are caused by cancer that has spread in the body.
A major advantage of the approach is that the target molecule ED-A is present in the majority of solid tumors. Vaccination against ED-A could therefore provide a treatment strategy with broad applications in cancer therapy. Furthermore, the researchers show that their strategy for immunization against a self-molecule is highly efficient and can be achieved with an adjuvant (immunostimulatory compound included in vaccines) that is acceptable for use in the clinic. The lack of potent, but at the same time non-toxic and biodegradable adjuvants has been a major limitation in the development of therapeutic vaccines.
Another important aspect is that therapeutic vaccination (endogenous production of the target antibodies) can provide a cost-efficient alternative to administration of large amounts of monoclonal antibodies, currently in clinical use for cancer and other diseases. The high costs associated with monoclonal antibody-based therapies puts a significant strain on the health-care economy, which may limit accessibility for patients.
"In conclusion, we believe therapeutic vaccination could provide a new, potent and cost-efficient treatment strategy for solid tumors and metastasizing cancer", says Anna-Karin Olsson.
INFORMATION:
Referens:
"Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer", Julia Femel, Elisabeth JM Huijbers, Falk Saupe, Jessica Cedervall, Lei Zhang, Pernilla Roswall, Erik Larsson, Helena Olofsson, Kristian Pietras, Anna Dimberg, Lars Hellman and Anna-Karin Olsson
ELSE PRESS RELEASES FROM THIS DATE:
2014-11-07
Tropical Cyclone 05B was meandering in the Bay of Bengal on Nov. 8, but forecasters expect it to move west and head toward east-central India for landfall. NASA-NOAA's Suomi NPP satellite captured a visible image of the tropical storm off India's coast.
When Suomi NPP flew over Tropical Cyclone 05B (TC05B) on Nov. 7 at 08:09 UTC (3:09 a.m. EST), the Visible Infrared Imaging Radiometer Suite or VIIRS instrument aboard captured a visible image of the storm. The VIIRS image showed a band of thunderstorms wrapping into the center from the northern quadrant, and fragmented ...
2014-11-07
Amyotrophic lateral sclerosis (ALS) is a very severe disease that mainly affects the motor system. Recently the focus of public attention thanks to a viral campaign (remember last summer's ALS Ice Bucket Challenge?), ALS leads to progressive paralysis and ultimately death. Among the lesser known symptoms of the disease are cognitive impairments, which may even involve full-blown dementia. One of them is a selective difficulty in understanding and using verbs denoting actions, which these patients find much more challenging to process compared to nouns denoting objects. ...
2014-11-07
This news release is available in German.
How can a sequence of dance steps best be learned? This question was the subject of a project led by researchers from Bielefeld University and the Palucca University of Dance in Dresden, who developed the study along with dancers and dance instructors. Together they researched whether dancers learn a dance sequence better by seeing or by listening, that is, if a dance instructor first demonstrates the sequence, or if he or she first gives a spoken explanation. The research article detailing the results of this study was recently ...
2014-11-07
Through the careful study of modern and early fossil tortoise, researchers now have a better understanding of how tortoises breathe and the evolutionary processes that helped shape their unique breathing apparatus and tortoise shell. The findings published in a paper, titled: Origin of the unique ventilatory apparatus of turtles, in the scientific journal, Nature Communications, on Friday, 7 November 2014, help determine when and how the unique breathing apparatus of tortoises evolved.
Lead author Dr Tyler Lyson of Wits University's Evolutionary Studies Institute, the ...
2014-11-07
Being shown pictures of others being loved and cared for reduces the brain's response to threat, new research from the University of Exeter has found.
The study discovered that when individuals are briefly presented pictures of others receiving emotional support and affection, the brain's threat monitor, the amygdala, subsequently does not respond to images showing threatening facial expressions or words. This occurred even if the person was not paying attention to the content of the first pictures.
Forty-two healthy individuals participated in the study, in which ...
2014-11-07
Last year CERN announced the finding of a new elementary particle, the Higgs particle. But maybe it wasn't the Higgs particle, maybe it just looks like it. And maybe it is not alone.
Many calculations indicate that the particle discovered last year in the CERN particle accelerator was indeed the famous Higgs particle. Physicists agree that the CERN experiments did find a new particle that had never been seen before, but according to an international research team, there is no conclusive evidence that the particle was indeed the Higgs particle.
The research team has ...
2014-11-07
This news release is available in German. Microbiologists and molecular biologists at ETH Zurich and the University of Bonn have discovered a new agent in fungi that kills bacteria. The substance, known as copsin, has the same effect as traditional antibiotics, but belongs to a different class of biochemical substances. Copsin is a protein, whereas traditional antibiotics are often non-protein organic compounds.
The researchers led by Markus Aebi, Professor of Mycology, discovered the substance in the common inky cap mushroom Coprinopsis cinerea that grows on horse ...
2014-11-07
An international research project, which includes researchers from the U. of Granada, has proved the need for campaigns to persuade parents of the benefits involved in having their children walk to school. This also includes work on the perception about the security of the paths their children need to follo won the way to school. This research points out, besides, the need for public administrations to actively campaign to persuade children and their families to walk more often as part of their daily routines.
Many different surveys have demonstrated that walking to school ...
2014-11-07
Since suitable studies are lacking, it remains unclear in which sperm analysis parameters assisted reproduction using intracytoplasmic sperm injection (ICSI) can be superior to in vitro fertilization (IVF). This is the conclusion of the final report published by the Institute for Quality and Efficiency in Health Care (IQWiG) on 6 November 2014.
Benefit assessment depending on parameters
The Federal Joint Committee (G-BA) commissioned IQWiG with the examination of two research questions: First, the researchers were to assess the benefit of ICSI in comparison with IVF ...
2014-11-07
Eribulin (trade name: Halaven) is approved for women with locally advanced or metastatic breast cancer in whom the disease has progressed despite prior drug therapy. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether the drug offers an added benefit over the appropriate comparator therapy in these patient groups.
According to the findings, there are both positive and negative effects. There is proof of minor added benefit for one group of patients. For other groups, there are hints or indications of lesser ...
LAST 30 PRESS RELEASES:
[Press-News.org] A vaccine directed against tumor blood vessels suppress tumor growth and metastasis
